SC
PGNY icon

Scholtz & Company’s Progyny PGNY Stock Holding History

Scholtz & Company’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-41,723
Closed -$2.1M – 61
2021
Q4 		$2.1M Buy
41,723
+430
+1% +$24.1K 0.68% 39
2021
Q3 		$2.31M Buy
41,293
+1,005
+2% +$55.5K 0.82% 36
2021
Q2 		$2.38M Sell
40,288
-76,870
-66% -$4.32M 0.81% 38
2021
Q1 		$5.21M Sell
117,158
-640
-0.5% -$29.9K 1.98% 20
2020
Q4 		$4.99M Buy
117,798
+6,933
+6% +$226K 1.95% 18
2020
Q3 		$3.26M Sell
110,865
-990
-0.9% -$27.3K 1.43% 28
2020
Q2 		$2.89M Buy
111,855
+33,445
+43% +$768K 1.44% 23
2020
Q1 		$1.66M Buy
+78,410
New +$2.15M 1.27% 26

Other funds holding PGNY

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Scholtz & Company's PGNY Position: Q1 2022 in Review

Scholtz & Company sold out of Progyny (PGNY) in Q1 2022, closing a stake of 41,723 shares — an estimated $2.1M sold.

Scholtz & Company first reported a position in PGNY in Q1 2020 and held it in 8 quarters. The position peaked at $5.21M in Q1 2021. 255 funds tracked by Wall St. Rank hold PGNY as of Q1 2022.

  • Scholtz & Company reported no remaining Progyny position as of Q1 2022 after selling out during the quarter.
  • Scholtz & Company sold 41,723 Progyny shares in Q1 2022, an estimated $2.1M.
  • Scholtz & Company first reported a position in Progyny in Q1 2020 and held it in 8 quarters.
  • Scholtz & Company's Progyny position peaked at $5.21M in Q1 2021.
  • 255 funds tracked by Wall St. Rank held Progyny as of Q1 2022.

Based on Scholtz & Company's 13F filing for Q1 2022, filed 16 May 2022.